03/27
Headlines

MannKind Corporation

Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

Mark DeFrance02 mins

MannKind Corp. (NASDAQ: MNKD) was raised to Neutral from Underweight by Piper Jaffray. MannKind Corporation (NASDAQ:MNKD) stock performance was 6.53% in last session and finished the day at $7.01. Traded volume was 16.68million shares in the last session and the average volume of the stock remained 10.11million shares. The beta of the stock remained 1.40….

Read More

Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Colin Pettis02 mins

Pfizer Inc. (NYSE:PFE)’s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses, but promised to keep key research jobs in Britain as part of its $106 billion takeover bid. Pfizer Inc. (NYSE:PFE) stock performance was 0.24% in last session and finished the day at $29.20. Traded volume was 26.29million…

Read More

Hot Biotech Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Chelsea Therapeutics (NASDAQ:CHTP)

Adam Keintzel03 mins

MannKind Corporation (NASDAQ:MNKD) loss of 14 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate by a penny but narrower than the year-ago loss by a penny. MannKind Corporation (NASDAQ:MNKD) did not generate any revenue in the first quarter of 2014, as in the year-ago quarter. Research and…

Read More

Hot Biotech Movers: VIVUS (NASDAQ:VVUS), MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Chris Lewis02 mins

VIVUS Inc (NASDAQ:VVUS) will be announcing its Q114 earnings results on Monday, May 5th. Analysts expect the company to announce earnings of ($0.37) per share and revenue of $11.40 million for the quarter. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -2.12% in last session and finished the day at $5.09. Traded volume was 1.34million shares in…

Read More

Healthcare Most Active Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT)

Richard Atkins02 mins

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is one of half a dozen drugmakers that have been rolling out generics of Eli Lilly’s ($LLY) top-selling blockbuster Cymbalta. The others are going to roll past the Israeli drugmaker after it recalled more than 1 million bottles of the antidepressant. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance…

Read More